AzTrials
AzTrials

E Cigarette UseNCT07886099

Circuit Breathing Exercise on Smoking Cessation Among Youth E-Cigarette Users

A study testing Circuit breathing, Diaphragmatic Breathing and Normal Breathing Condition in people with E Cigarette Use, run by Chulalongkorn University at 1 site in Thailand.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate the acute effects of a circuit breathing intervention on nicotine withdrawal symptoms and respiratory parameters among youth who use e-cigarettes. Read more about this study

Who is it for?
Ages 15 to 25 yearsHealthy volunteers can take part
Conditions the study is for
E Cigarette Use
What is being tested?
Circuit breathing, Diaphragmatic Breathing and Normal Breathing Condition
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteThailand
Study dates
15 Aug 2026to 30 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Male or female aged 15-25 years.
  • Regular e-cigarette use for at least six months and current e-cigarette use, defined as use on at least one day per week or at least 10 puffs per day during the past 30 days.
  • Not regularly physically active, defined as exercising fewer than two times per week during the preceding six months.
  • Able to understand instructions, communicate effectively, and cooperate with the research procedures.
  • No history of cardiovascular disease or respiratory disease, such as asthma or chronic obstructive pulmonary disease.
  • No uncontrolled hypertension. Participants with controlled hypertension must have resting blood pressure ≤140/90 mmHg.
Show all 9Show fewer
  • Able to move independently without assistance or assistive devices.
  • Willing to participate and provide informed consent.
  • For participants younger than 18 years, consent from a parent or legally authorized representative is required.

Who cannot join

  • Development of an illness, injury, or other circumstance that prevents continued participation.
  • Withdrawal of consent or unwillingness to continue participation.
  • Current use of illicit drugs or other tobacco/nicotine products, including conventional cigarettes, shisha/hookah, roll-your-own tobacco, or other nicotine-containing products.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wannaporn Tongtako, Ph.D. contact

0879823131

wannaporn.t@chula.ac.th

Thailand1 site, 1 recruiting
  • Faculty of Sports Science, Chulalongkorn University

    Bangkok, Bangkok, 10330

    Dr.Wannaporn Tongtako, 0879823131, wannaporn.t@chula.ac.th

    Recruiting

Other trials in Thailand

About this study

Official title: Acute Effects of Circuit Breathing Exercise on Smoking Cessation and Respiratory Function Among Youth E-Cigarette Users

This study aims to investigate the acute effects of a circuit breathing intervention on nicotine withdrawal symptoms and respiratory parameters among youth who use e-cigarettes.

Read the detailed description

A randomized crossover study will include 20 male and female e-cigarette users aged 15-25 years. Each participant will undergo three breathing conditions: circuit breathing, diaphragmatic breathing, and normal breathing, with a washout period of at least one week between sessions. The study will evaluate the acute effects of each breathing condition on nicotine withdrawal symptoms, e-cigarette dependence, physiological variables (resting heart rate and blood pressure), peak nasal inspiratory flow (PNIF), and fractional exhaled nitric oxide (FeNO).

Conditions
E Cigarette Use
Being tested
Circuit breathing, Diaphragmatic Breathing, Normal Breathing Condition
Keywords
Circuit breathing, Nicotine withdrawal symptoms, E Cigarette, Fractional exhaled nitric oxide, Respiratory Function
Medical subject headings
Vaping, Respiratory Aspiration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Circuit breathingOther

    The circuit breathing intervention consists of five stations: paper suction using a straw, blowing a toy pinwheel, incentive spirometry, balloon blowing, and weighted diaphragmatic breathing. Participants will rest for 1 minute between stations.

  • Diaphragmatic BreathingOther

    The diaphragmatic breathing exercise will consist of inhaling through the nose for 4 seconds and exhaling through the nose for 6 seconds, continuously for 10 minutes per set. Participants will rest for 1 minute between sets and complete a total of 3 sets.

  • Normal Breathing ConditionOther

    Participants will breathe normally through the nose without deliberately controlling the rate, rhythm, or depth of breathing. Breathing will remain at each participant's natural pace for approximately 30 minutes.

Study groups in NCT07886099
Study groupRoleWhat they receive
Circuit BreathingExperimentalNot described
Receives: Other: Circuit breathing
Diaphragmatic BreathingExperimentalNot described
Receives: Other: Diaphragmatic Breathing
Normal BreathingExperimentalNot described
Receives: Other: Normal Breathing Condition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. E-cigarette Dependence

    E-cigarette dependence will be assessed using the Penn State Electronic Cigarette Dependence Index, adapted by Sornsenee et al. (2025). The questionnaire consists of 10 items, with a maximum total score of 20. Scores are interpreted as follows: 0-3 indicates no e-cigarette dependence, 4-8 indicates low dependence, 9-12 indicates moderate dependence, and 13 or higher indicates high dependence.

    Measured: Baseline for demographic data.

  2. Nicotine Withdrawal Symptoms

    Nicotine withdrawal symptoms will be assessed using the Thai version of the Minnesota Nicotine Withdrawal Scale-Revised (MNWS) (Hughes \& Hatsukami, 2008), translated by Sirirat Kanokururot and Sunida Preechawong (2010). This self-report questionnaire measures the perceived severity of nicotine withdrawal symptoms. It consists of 9 items rated on a 5-point scale ranging from 0 (no symptoms) to 4 (severe symptoms). The total score ranges from 0 to 36, with a score of 0 indicating no nicotine withdrawal symptoms and a score of 36 indicating the most severe nicotine withdrawal symptoms.

    Measured: Immediately before and immediately after each breathing intervention session.

Secondary outcomes (2)
  1. Fractional Exhaled Nitric Oxide (FeNO)

    FeNO will be measured using a device equipped with a bacterial filter and mouthpiece. Participants will place their lips around the mouthpiece and exhale into the device for 6 seconds while maintaining the indicator ball within the designated range. Results will be recorded in parts per million (ppm).

    Measured: Immediately before and immediately after each breathing intervention session.

  2. Peak Nasal Inspiratory Flow (PNIF)

    Peak nasal inspiratory flow will be measured using a peak nasal inspiratory flow meter. Participants will perform the breathing maneuver according to the study procedure, and the measurement will be recorded in liters per second (L/s).

    Measured: Immediately before and immediately after each breathing intervention session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2026
  2. Study start15 Aug 2026
  3. Primary completion15 Oct 2026 (estimated)
  4. Study completion30 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07886099
Sponsor's protocol ID
EX PHYSIO SPSC 14
Status last verified
Oct 2026
First submitted
10 Oct 2026
Last updated
21 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Circuit breathing, Diaphragmatic Breathing and Normal Breathing Condition in people with E Cigarette Use, run by Chulalongkorn University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wannaporn Tongtako, Ph.D. (0879823131, wannaporn.t@chula.ac.th), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

E-cigarette Dependence (time frame: Baseline for demographic data.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in